Kindeva has been selected among a select group of contract development and manufacturing organizations (CDMOs) to participate in BioTools Innovator (BTI) VANGUARD’s Level-UP XR program, an initiative designed to evaluate the effectiveness of extended reality (XR) technologies in onboarding biopharmaceutical manufacturing technicians.
As one of three selected company pairs, Kindeva will receive up to $300,000 in non-dilutive funding to conduct a real-world pilot study under good manufacturing practice (GMP) conditions over a 12-month period.
Through the Level UP-XR program, CDMOs and XR technology companies will work together to test immersive training platforms for technicians entering GMP environments. The pilot will compare the impact of XR-based onboarding outcomes with Kindeva’s established non-XR training protocols to help establish new practices for biopharmaceutical workforce training.
Kindeva brings GMP manufacturing solutions for a range of drug delivery technologies, including pulmonary, nasal, sterile injectable, microneedle and transdermal, to the pilot, creating ample real-world settings to evaluate the XR approach.
The pilot has now launched and is set to run through June 2027 to help enable the biopharmaceutical industry to assess the potential benefits of XR training for biomanufacturing technician onboarding and establish new industry-wide baselines and best practices.
Learn more about Kindeva’s participation in Level UP-XR and the upcoming pilot in the full press release below.
Related news
Explore more of our latest news and announcements, where the demands of today meet the possibilities of tomorrow.
Kindeva commemorates 70 years of the pMDI as inventors are inducted into the ‘National Inventors Hall of Fame’
23RD MARCH 2026: Kindeva, a global CDMO and drug delivery innovator, commemorates 70 years today, since the invention of the pressurized metered dose inhaler (pMDI), a breakthrough therapy that transformed respiratory care across the globe. Marking this momentous milestone, the device’s inventors, Kindeva alumni George Maison, Irving Porush and Charles Thiel will be officially inducted […]
Learn MoreKindeva Drug Delivery completes registration batch at state-of-the-art aseptic injectable fill finish facility
ST. LOUIS; Oct. 8, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a leading global CDMO, today announced two key milestones for its state-of-the-art Bridgeton, MO, facility. The site has successfully completed its first registration batch on its groninger high-volume vial line. This achievement showcases the facility’s readiness to meet the growing demand for injectable […]
Learn MoreKindeva Drug Delivery’s Woodbury analytical services site: Inspected by the FDA
WOODBURY, Minn.; July 16, 2024 (Business Wire) – Global drug-device combination product CDMO Kindeva Drug Delivery today announced that their Woodbury, MN facility has been inspected, successfully classified by the FDA, and continues to support clients through the analytical services global business unit. The new business unit, launched earlier this year, supports both integrated and […]
Learn MoreKindeva Drug Delivery expands Loughborough, UK, facilities at Charnwood campus to support growth of green propellant commercialization
LOUGHBOROUGH, UK, WOODBURY, Minn., and ST. LOUIS, Mo.; June 4, 2024 (Business Wire) – Leading global drug-device combination product CDMO Kindeva Drug Delivery (Kindeva) today announced the expansion of their Loughborough, U.K., facilities at the Charnwood Campus Science Innovation and Technology Park. This strategic move by Kindeva supports the growth of green propellant commercialization and […]
Learn MoreKindeva Drug Delivery invests in second manufacturing line for greener inhalers at UK manufacturing site
WOODBURY, Minn. and ST. LOUIS, Mo.; May 6, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility. This new line will […]
Learn MoreKindeva Drug Delivery launches new Analytical Services Global Business Unit
WOODBURY, Minn. and ST. LOUIS, Mo.; Jan. 31, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical, and medical device sector. For more than half […]
Learn MoreU.K. Government grant unlocks £33M investment with Kindeva Drug Delivery for greener inhaler future
WOODBURY, Minn. and ST. LOUIS, Mo.; Aug. 3, 2023 (Business Wire) — Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that the company has received a grant from the U.K. Government’s Life Sciences Innovation Manufacturing Fund (LSIMF), unlocking a £33 million investment with Kindeva toward enhancing […]
Learn MoreMeridian Medical Technologies, a Kindeva Drug Delivery company, investing $100+ Million in Bridgeton, Missouri, expansion
St. Louis, Mo. and St. Paul, Minn.; April 11, 2023 (Business Wire) – Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 […]
Learn MoreKindeva Drug Delivery to manufacture new, greener inhalers at UK manufacturing site to help cut carbon emissions
February 16, 2022 – One of the UK’s biggest asthma inhaler manufacturers has today announced its intention to invest in its UK manufacturing site to support the development of a new generation of greener inhalers, designed to help support the National Health Service (NHS) to cut a contributor to its emissions. The new inhalers will […]
Learn MoreManufacturing More Tomorrows™
Partner with us and benefit from a team with technical expertise and a passion for purpose. As a true partner, strategically minded and dedicated to your lasting legacy, we provide customized solutions tailored to your precise requirements. From development to commercial manufacturing and beyond, our CDMO solutions are designed to help your product progress with purpose.
